Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05242445
What this trial is testing

Cetrelimab in Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Research & Development, LLC 11
Large-scale testing (Phase 3)Study completedNCT00290303
What this trial is testing

Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants

Who this might be right for
Haemophilus Influenzae Type bDiphtheriaWhole Cell Pertussis+2 more
GlaxoSmithKline 996
Early research (Phase 1)UnknownNCT04685603
What this trial is testing

Dendritic Cell Vaccine to Prevent COVID-19

Who this might be right for
COVID-19
Indonesia-MoH 27
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Testing effectiveness (Phase 2)Study completedNCT00055237
What this trial is testing

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

Who this might be right for
Kaposi's SarcomaHIV InfectionsHIV Seronegativity
National Cancer Institute (NCI) 19
Not applicableWithdrawnNCT04418531
What this trial is testing

Convalescent Antibodies Infusion in COVID 19 Patients

Who this might be right for
Pneumonia, ViralCorona Virus Infection
Piero Luigi Ruggenenti
Large-scale testing (Phase 3)Ended earlyNCT04425629
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 10,078
Post-approval studies (Phase 4)Study completedNCT05305651
What this trial is testing

Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 217
Large-scale testing (Phase 3)Ended earlyNCT04369469
What this trial is testing

Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia

Who this might be right for
COVID-19 Severe PneumoniaAcute Lung InjuryAcute Respiratory Distress Syndrome+1 more
Alexion Pharmaceuticals, Inc. 202
Large-scale testing (Phase 3)Study completedNCT01444781
What this trial is testing

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

Who this might be right for
DiphtheriaTetanusWhooping Cough+2 more
Sanofi Pasteur, a Sanofi Company 1,106
Not applicableUnknownNCT05906459
What this trial is testing

Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)

Who this might be right for
Hepatitis C Virus Infection
Huashan Hospital 20,000
Post-approval studies (Phase 4)Study completedNCT00144313
What this trial is testing

VaxTeen Hepatitis B Vaccine Booster Study

Who this might be right for
Hepatitis
Centers for Disease Control and Prevention 60
Not applicableStudy completedNCT04964024
What this trial is testing

SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

Who this might be right for
COVID-19 Infection
Central Hospital, Nancy, France 1,293
Not applicableWithdrawnNCT05069636
What this trial is testing

Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy

Who this might be right for
COVID-19
Rowan University
Early research (Phase 1)UnknownNCT04717830
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Testing effectiveness (Phase 2)WithdrawnNCT05156645
What this trial is testing

Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19

Who this might be right for
COVID-19
Sinocelltech Ltd.
Early research (Phase 1)Study completedNCT04773665
What this trial is testing

Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

Who this might be right for
Covid19
VBI Vaccines Inc. 114
Not applicableStudy completedNCT06357819
What this trial is testing

INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation

Who this might be right for
Hepatitis C
bioLytical Laboratories 405
Early research (Phase 1)Active Not RecruitingNCT06965751
What this trial is testing

A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19

Who this might be right for
COVID-19 Infection
University of Melbourne 32
Early research (Phase 1)Study completedNCT00001136
What this trial is testing

The Effectiveness of an HIV Vaccine (ALVAC vCP205) to Boost Immune Functions in HIV-Negative Volunteers Who Have Already Received an HIV Vaccine

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 60
Next Page